Applications for this job have closed. This page will redirect to AstraZeneca UK employer page in 10 seconds.

Vice President, OBU Medical Affairs, GU/GYN

AstraZeneca UK

Location: Cambridgeshire, Gaithersburg, Maryland

Job Type: Full time

Posted


Do you have expertise in, and passion for Medical Affairs in Oncology? Would you like to apply your expertise to impact the Vice President, OBU Medical Affairs, GU/GYN role in a company that follows the science and turns ideas into life changing medicines? Then AstraZeneca might be the one for you!

At AstraZeneca, we put patients first and strive to meet their unmet needs worldwide. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. If you are swift to action, confident to lead, willing to collaborate, and curious about what science can do, then you’re our kind of person.

Reporting to the SVP, OBU Medical Affairs, the VP role has full responsibility for establishing, implementing and delivering a world class, best in industry long range Global Medical tumor strategy for the Oncology business, bringing maximum benefits to clinical community and patients.

What You'll Do:

  • Member of the Global Core Medical Leadership Team (CMLT) and will be the accountable medical lead on the Tumor Council
  • Lead of the Cross Functional Tumor Strategy, collaborating and partnering with R&D and Commercial Leaders
  • Identify and strive for innovation in the medical strategy and approach to provide health care solutions to clinicians, patients and payers
  • Accountable to Senior SET/SET- 1 and external stakeholder management and communication
  • As Tumor lead, you will be accountable for ensuring cross asset prioritization and alignment for your tumor area, whilst working with other Medical Tumor VP’s on long term and immediate prioritization activities including demand planning to ensure the enterprise oncology medical delivery plan is achieved and balanced
  • Responsible for the development and implementation of GMA evidence and confidence building strategies in the Tumor Area, ensuring effective collaboration with other key functions within GMA (Medical Excellence, Evidence Generation, Patient Centricity, Strategy and Planning) and regional/marketing company (MC) Medical Affairs (MA)
  • Accountable for the evidence generation strategy for all non-indication seeking (in primary intent) evidence generation. This includes interventional and non-interventional studies whether internally or externally sponsored.

Essential Requirements

  • PhD / Advanced Scientific degree.
  • 10+ years leadership experience in pharmaceutical or biotechnology industry, including leadership positions in Medical Affairs and/or R&D, with a proven track record for developing & implementing medical strategies and plans
  • Strong connections to the delivery of healthcare in the assigned TA including established relationships with relevant therapeutic area experts
  • Understanding of the sophisticated and evolving Medical Affairs space with insights about trends, opportunities, risks, and an understanding of external partners (physicians, patients, payers)
  • Experience in establishing strategic alliances and partnerships with health care institutions/Key opinion leaders and/or academic institutions
  • Experience in product development, academic research institutes, life cycle management
  • Success in developing and running pharmaceutical product strategies and/or leading TA strategy and planning and/or financial planning and budgeting process
  • Consistent track record in delivering new initiatives, capabilities and leading large scale impactful medical initiatives

Desirable Requirements

  • MD (Strongly Preferred)
  • Clinical experience in disease management
  • Highly desired: Oncology specialist qualification
  • In-market / country medical leadership is advantageous

Why AstraZeneca?

At AstraZeneca when we see an opportunity for change, we seize it and make it happen, because any opportunity no matter how small, can be the start of something big. Delivering life-changing medicines is about being entrepreneurial - finding those moments and recognizing their potential. Join us on our journey of building a new kind of organization to reset expectations of what a bio-pharmaceutical company can be. This means we’re opening new ways to work, groundbreaking methods and bringing unexpected teams together. Interested? Come and join our journey.

Are you already imagining yourself joining our team? Good, because we can’t wait to hear from you.

AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We follow all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements

Date Posted

15-Sep-2023

Closing Date

01-Oct-2023

AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorisation and employment eligibility verification requirements. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or protected veteran status.

AstraZeneca requires all US employees to be fully vaccinated for COVID-19 but will consider requests for reasonable accommodations as required by applicable law.